Literature DB >> 35432491

Fabrication of subunit nanovaccines by physical interaction.

HaoLin Chen1, Hong Liu2, LiXin Liu1, YongMing Chen1,3.   

Abstract

Vaccines can improve the quality of human life by preventing the burden of infectious diseases. Also, vaccination is becoming a powerful medication for preventing and treating tumors. Various vaccines have been developed based on the origin of the antigens. Herein, we focus on the subunit vaccines whose antigens are proteins or peptides. The advantage of subunit vaccines is safety for recipients; however, the immunogenicity of subunit antigens is relatively low. Nanoparticular delivery systems have been applied to improve the immunocompetence of subunit vaccines by targeting lymph nodes, and effectively present antigens to immune cells. Moreover, adding appropriate molecular adjuvants may strengthen the antigens to elicit immune response. In this perspective article, we first elucidate the characteristics of immunity induced by subunit nanovaccines and then summarize the strategies to fabricate subunit nanovaccines with delivering materials. Herein we highlight non-covalent interaction to fabricate nanoparticular subunit vaccines. © Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2022.

Entities:  

Keywords:  immunotherapy; nanoparticle; nanovaccine; protein/peptide; subunit

Year:  2022        PMID: 35432491      PMCID: PMC9004205          DOI: 10.1007/s11431-021-2011-7

Source DB:  PubMed          Journal:  Sci China Technol Sci        ISSN: 1869-1900


  62 in total

Review 1.  Recent advances in peptide-based subunit nanovaccines.

Authors:  Mariusz Skwarczynski; Istvan Toth
Journal:  Nanomedicine (Lond)       Date:  2014-12       Impact factor: 5.307

Review 2.  Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges.

Authors:  José L Tlaxca; Scott Ellis; Richard L Remmele
Journal:  Adv Drug Deliv Rev       Date:  2014-10-12       Impact factor: 15.470

Review 3.  Up-to-date vaccine delivery systems: robust immunity elicited by multifarious nanomaterials upon administration through diverse routes.

Authors:  Changshun Hou; Bo Yi; Jieke Jiang; Yung-Fu Chang; Xi Yao
Journal:  Biomater Sci       Date:  2019-02-26       Impact factor: 6.843

4.  Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes.

Authors:  Zhiyu He; Yizong Hu; Zaizhi Gui; Yang Zhou; Tianqi Nie; Jinchang Zhu; Zhijia Liu; Kuntao Chen; Lixin Liu; Kam W Leong; Peng Cao; Yongming Chen; Hai-Quan Mao
Journal:  J Control Release       Date:  2019-03-17       Impact factor: 9.776

5.  A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy.

Authors:  Jun Xu; Jia Lv; Qi Zhuang; Zongjin Yang; Zhiqin Cao; Ligeng Xu; Pei Pei; Chenya Wang; Hanfei Wu; Ziliang Dong; Yu Chao; Chao Wang; Kai Yang; Rui Peng; Yiyun Cheng; Zhuang Liu
Journal:  Nat Nanotechnol       Date:  2020-11-02       Impact factor: 39.213

6.  Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus.

Authors:  Mireille T M Vossen; Mi-Ran Gent; Jan F L Weel; Menno D de Jong; René A W van Lier; Taco W Kuijpers
Journal:  J Infect Dis       Date:  2004-05-26       Impact factor: 5.226

7.  A polyphenol-metal nanoparticle platform for tunable release of liraglutide to improve blood glycemic control and reduce cardiovascular complications in a mouse model of type II diabetes.

Authors:  Zhiyu He; Tianqi Nie; Yizong Hu; Yang Zhou; Jinchang Zhu; Zhijia Liu; Lixin Liu; Kam W Leong; Yongming Chen; Hai-Quan Mao
Journal:  J Control Release       Date:  2019-12-12       Impact factor: 9.776

8.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Authors:  Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

Review 9.  Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health.

Authors:  Chelsea N Fries; Elizabeth J Curvino; Jui-Lin Chen; Sallie R Permar; Genevieve G Fouda; Joel H Collier
Journal:  Nat Nanotechnol       Date:  2020-08-17       Impact factor: 39.213

Review 10.  Recent Advances and Future Perspectives in Polymer-Based Nanovaccines.

Authors:  Natassa Pippa; Maria Gazouli; Stergios Pispas
Journal:  Vaccines (Basel)       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.